Unlock instant, AI-driven research and patent intelligence for your innovation.

Epoxy platinum complex and its preparation method and use

A technology of platinum complexes and epoxyplatinum, applied in the field of medicine, can solve problems such as systemic toxicity and harmful side effects

Active Publication Date: 2022-08-02
HEBEI MEDICAL UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But these drugs often cause severe systemic toxicity, unwanted side effects and inevitable resistance problems

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Epoxy platinum complex and its preparation method and use
  • Epoxy platinum complex and its preparation method and use
  • Epoxy platinum complex and its preparation method and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0083] Example 1 Preparation of 5-(4-hydroxyphenyl)thiophene-2-aldehyde

[0084]

[0085] 4-iodophenol (2.2g, 10mmol), 30ml of toluene and 30ml of ethanol were mixed, stirred at room temperature for 5 minutes, and then added 30ml of 2mol / L K 2 CO 3 The solution continued to be stirred evenly. Vacuum, replace nitrogen, repeat the operation 3 times, under nitrogen protection, add Pd (PPh 3 ) 4 (350 mg, 0.3 mmol) and 5-formyl-2-thiopheneboronic acid (1.87 g, 12 mmol), then the mixture was warmed to 85°C and stirring was continued for 8 hours. After the reaction was completed, the temperature was lowered to room temperature, and the solvent was spin-dried by a rotary evaporator, and then chromatographed on a silica gel column with dichloromethane:ethyl acetate=20:1 (V / V) as the eluent to obtain 920 mmg of yellow powder, with a yield of 920 mmg. 45%. 1 H NMR (300MHz, CDCl 3 )δ9.89(s,1H),δ7.74(d,1H,J=3.9Hz),δ7.61(m,2H),δ7.31(d,1H,J=3.9Hz),δ6.39 (m, 2H), δ 4.97 (s, 1H).

Embodiment 2

[0086] Preparation of Example 2 Ligand 3

[0087]

[0088] 5-(4-Hydroxyphenyl)thiophen-2-aldehyde (920 mmg, 4.5 mmol) was added to 200 mL of water, stirred, then o-aminothiophenol (1.25 g, 10 mmol) was added, and the temperature was raised to 110° C. to react for 3 hours. After cooling to room temperature, extract with ether, spin dry the solvent, and purify by silica gel column chromatography with dichloromethane as the eluent to obtain 900 mg of orange powder with a yield of 64%. 1 H NMR (300MHz, CDCl 3 )δ8.06(d,1H,J=8.1Hz),δ7.86(d,1H,J=7.8Hz),δ7.63(d,1H,J=4.2Hz),δ7.60(m,2H ),δ7.52(t,1H,J=7.2Hz),,δ7.41(t,1H,J=7.2Hz),δ7.25(d,1H,J=4.2Hz),δ6.93(m ,2H).ESI-HRMS([C17H11NOS2+H] + ): Calculated value 310.03, measured value 310.0335.

Embodiment 3

[0089] Example 3 Preparation of Ligand 4

[0090]

[0091] Ligand 3 (520 mg, 1.68 mmol) was stirred and dissolved in 15 mL of acetonitrile, evacuated, and replaced with nitrogen. After repeated operations 3 times, under nitrogen protection, sodium hydride (80 mmg, 2 mmol) was added, and then slowly added dropwise to the system. A dilute solution of 3-hydroxybenzyl bromide (628 mg, 3.36 mmol) in acetonitrile was added. After the dropwise addition, the temperature of the mixed solution was raised to 60° C. and the reaction was continued for 12 hours. After the reaction was completed, the temperature was lowered to room temperature, the solvent was spin-dried by a rotary evaporator, and then chromatographed on a silica gel column with dichloromethane as the eluent to obtain 100 mmg of yellow powder with a yield of 14%. 1 H NMR (300MHz, CDCl 3 )δ8.07(d,1H,J=8.1Hz),δ7.89(d,1H,J=7.8Hz),δ7.66(m,3H),δ7.52(t,1H,J=7.2Hz ),,δ7.41(t,1H,J=7.2Hz),δ7.29(m,3H),δ7.04(d,2H,J=6.6Hz),δ6.96(m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an epoxy platinum complex and a preparation method and application thereof. The provided epoxy platinum complex has the structure of formula I, and the epoxy platinum complex can recognize tyrosinase through fluorescence change. With anti-melanoma and breast cancer cell activity, this series of compounds can be used as anti-tumor drugs, laying the foundation for photodynamic therapy of tumors.

Description

technical field [0001] The invention belongs to the technical field of medicine, in particular, the invention relates to an epoxy platinum complex and a preparation method thereof, and also relates to the application of the epoxy platinum complex to melanoma cell recognition and photodynamic therapy, and the compound as a Pharmaceutical compositions of active ingredients and uses of the compositions. Background technique [0002] In 1998, Funkhouser, an expert and CEO of ParmaNetics, proposed the concept of "Theranostic" (therapeutic diagnostics). It is defined as a single agent that combines diagnostic and therapeutic capabilities. That is, the therapeutic drug and the diagnostic imaging agent are provided simultaneously at the same dose, thereby enabling simultaneous or sequential diagnosis and treatment. Therapeutic diagnostics, combining therapeutic and diagnostic functions in the same "molecule", has the potential to overcome the undesirable differences in biodistribu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00A61K41/00A61K31/555A61P35/00
CPCC07F15/0086A61K41/0057A61P35/00
Inventor 刘异凡
Owner HEBEI MEDICAL UNIVERSITY